Snipstad Sofie, Vikedal Krister, Maardalen Matilde, Kurbatskaya Anna, Sulheim Einar, Davies Catharina de Lange
Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway; Cancer Clinic, St. Olav's Hospital, Trondheim, Norway.
Department of Physics, Norwegian University of Science and Technology, Trondheim, Norway.
Adv Drug Deliv Rev. 2021 Oct;177:113847. doi: 10.1016/j.addr.2021.113847. Epub 2021 Jun 25.
Successful delivery of drugs and nanomedicine to tumors requires a functional vascular network, extravasation across the capillary wall, penetration through the extracellular matrix, and cellular uptake. Nanomedicine has many merits, but penetration deep into the tumor interstitium remains a challenge. Failure of cancer treatment can be caused by insufficient delivery of the therapeutic agents. After intravenous administration, nanomedicines are often found in off-target organs and the tumor extracellular matrix close to the capillary wall. With circulating microbubbles, ultrasound exposure focused toward the tumor shows great promise in improving the delivery of therapeutic agents. In this review, we address the impact of focused ultrasound and microbubbles to overcome barriers for drug delivery such as perfusion, extravasation, and transport through the extracellular matrix. Furthermore, we discuss the induction of an immune response with ultrasound and delivery of immunotherapeutics. The review discusses mainly preclinical results and ends with a summary of ongoing clinical trials.
将药物和纳米药物成功递送至肿瘤需要一个功能正常的血管网络、穿过毛细血管壁的渗出、穿透细胞外基质以及细胞摄取。纳米药物有许多优点,但深入肿瘤间质仍然是一个挑战。癌症治疗失败可能是由于治疗药物递送不足所致。静脉给药后,纳米药物常常出现在非靶器官以及靠近毛细血管壁的肿瘤细胞外基质中。借助循环微泡,聚焦于肿瘤的超声照射在改善治疗药物递送方面显示出巨大潜力。在本综述中,我们阐述了聚焦超声和微泡对克服药物递送障碍(如灌注、渗出和穿过细胞外基质的转运)的影响。此外,我们讨论了超声诱导免疫反应以及免疫治疗药物的递送。本综述主要讨论临床前结果,并以正在进行的临床试验总结作为结尾。